Volume 22, Issue 1, Pages (January 1999)

Slides:



Advertisements
Similar presentations
Targeting Visceral Fat by Intraperitoneal Delivery of Novel AAV Serotype Vector Restricting Off-Target Transduction in Liver  Wei Huang, Xianglan Liu,
Advertisements

Volume 54, Issue 6, Pages (June 2007)
Volume 26, Issue 2, Pages (January 2016)
Volume 66, Issue 6, Pages (June 2010)
Volume 13, Issue 2, Pages (October 2015)
Volume 79, Issue 3, Pages (August 2013)
Volume 22, Issue 4, Pages (April 2014)
Volume 16, Issue 8, Pages (August 2008)
Volume 7, Issue 3, Pages (May 2014)
VEGF Gene Delivery to Muscle
Intracranial Tumor Cell Migration and the Development of Multiple Brain Metastases in Malignant Melanoma  Trude G. Simonsen, Jon-Vidar Gaustad, Einar.
Parabrachial CGRP Neurons Control Meal Termination
Volume 22, Issue 8, Pages (August 2014)
Activation of VTA GABA Neurons Disrupts Reward Consumption
Volume 15, Issue 1, Pages (January 2007)
Volume 18, Issue 5, Pages (May 2010)
Critical Role of Complement and Viral Evasion of Complement in Acute, Persistent, and Latent γ-Herpesvirus Infection  Sharookh B. Kapadia, Beth Levine,
Volume 20, Issue 6, Pages (December 2014)
Volume 26, Issue 17, Pages (September 2016)
Volume 8, Issue 1, Pages (January 2017)
Molecular Therapy - Methods & Clinical Development
Olfactory neurons are interdependent in maintaining axonal projections
Manipulating the Cellular Circadian Period of Arginine Vasopressin Neurons Alters the Behavioral Circadian Period  Michihiro Mieda, Hitoshi Okamoto, Takeshi.
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Qi Wu, Maureen P. Boyle, Richard D. Palmiter  Cell 
Genetic Ablation and Restoration of the Olfactory Topographic Map
Growth Arrest Failure, G1 Restriction Point Override, and S Phase Death of Sensory Precursor Cells in the Absence of Neurotrophin-3  Wael M ElShamy, Lena.
Volume 15, Issue 9, Pages (May 2016)
Volume 27, Issue 16, Pages e3 (August 2017)
Volume 51, Issue 6, Pages (September 2006)
Targeting Visceral Fat by Intraperitoneal Delivery of Novel AAV Serotype Vector Restricting Off-Target Transduction in Liver  Wei Huang, Xianglan Liu,
Volume 19, Issue 1, Pages (January 2014)
NMDA Receptors in Dopaminergic Neurons Are Crucial for Habit Learning
Volume 16, Issue 8, Pages (August 2008)
Inhibitory Interplay between Orexin Neurons and Eating
Volume 18, Issue 4, Pages (April 2010)
Molecular Therapy - Methods & Clinical Development
Volume 88, Issue 3, Pages (November 2015)
Volume 25, Issue 12, Pages (December 2017)
Volume 12, Issue 4, Pages (October 2005)
Volume 44, Issue 3, Pages (October 2004)
Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome  Jon Ortiz-Abalia, Ignasi Sahún, Xavier Altafaj,
Volume 27, Issue 7, Pages (April 2017)
Volume 21, Issue 1, Pages (January 2013)
Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo  Christian.
Volume 9, Issue 1, Pages (January 2009)
Molecular Therapy - Methods & Clinical Development
Volume 21, Issue 11, Pages (December 2017)
Volume 9, Issue 6, Pages (June 2009)
Hsp70 Gene Transfer by Adeno-associated Virus Inhibits MPTP-Induced Nigrostriatal Degeneration in the Mouse Model of Parkinson Disease  Zhizhong Dong,
Volume 66, Issue 6, Pages (June 2010)
Volume 26, Issue 7, Pages e4 (February 2019)
Activation of VTA GABA Neurons Disrupts Reward Consumption
Volume 13, Issue 3, Pages (March 2006)
Volume 27, Issue 7, Pages (April 2017)
Zu-Lin Chen, Sidney Strickland  Cell 
Volume 6, Issue 3, Pages (September 2002)
Volume 23, Issue 8, Pages (August 2015)
Sorting Nexin 27 Regulation of G Protein-Gated Inwardly Rectifying K+ Channels Attenuates In Vivo Cocaine Response  Michaelanne B. Munoz, Paul A. Slesinger 
NCS-Rapgef2-dependent ERK activation in mouse NAc following D1 dopamine receptor agonist SKF and psychostimulants D-amphetamine or cocaine administration.
Volume 30, Issue 3, Pages (May 2001)
Volume 21, Issue 11, Pages (December 2017)
Protein Transduction Domain-mediated Delivery of QBP1 Suppresses Polyglutamine- induced Neurodegeneration In Vivo  H Akiko Popiel, Yoshitaka Nagai, Nobuhiro.
Volume 13, Issue 1, Pages (January 2006)
Volume 20, Issue 4, Pages (October 2014)
Volume 15, Issue 5, Pages (May 2007)
Volume 90, Issue 6, Pages (September 1997)
Volume 66, Issue 6, Pages (June 2010)
Molecular Therapy - Methods & Clinical Development
Presentation transcript:

Volume 22, Issue 1, Pages 167-178 (January 1999) Viral Gene Delivery Selectively Restores Feeding and Prevents Lethality of Dopamine- Deficient Mice  Mark S Szczypka, Ronald J Mandel, Brian A Donahue, Richard O Snyder, Stuart E Leff, Richard D Palmiter  Neuron  Volume 22, Issue 1, Pages 167-178 (January 1999) DOI: 10.1016/S0896-6273(00)80688-1

Figure 1 Viral Gene Therapy Promotes Survival of DA−/− Mice DA−/− mice were injected with two rAAV vectors expressing either human TH or human GTPCH1, and survival was monitored after removal of L-DOPA. Three groups were generated via bilateral direct injection; mix (rAAV-TH + rAAV-GTPCH1), TH (rAAV-TH), and GTPCH1 (rAAV-GTPCH1). L-DOPA was removed 7 days following surgery. Food consumption and body weight measurements were recorded daily as criteria for survival. Mice that lost >20% body weight in 3 days and looked moribund were considered as nonsurvivors. (A) Survival following termination of L-DOPA treatment 7 days postsurgery. (B) Survival following termination of L-DOPA treatment 2 months postsurgery. Neuron 1999 22, 167-178DOI: (10.1016/S0896-6273(00)80688-1)

Figure 2 Food Intake and Body Weight Measurements of Virally Transduced DA−/− Mice following Termination of L-DOPA Treatment (A) Daily food intake of mice injected with rAAV-TH + rAAV-GTPCH1 (mix), rAAV-TH alone (TH), and rAAV-GTPCH1 alone (GTPCH1) was monitored following removal of L-DOPA. Average food consumption by wild-type and DA−/− mice are indicated by dotted lines. Nonsurvivors are indicated by the cross. (B) Comparison of daily food intake of wild-type (WT), DA−/−, and virally transduced mice (TH, Mix, and GTPCH1) averaged over a period of a week. *p < 0.05 compared with DA−/− mice and **p < 0.05 compared with wild-type and mixed vector mice (one way ANOVA followed by Post Hoc analysis). (C) Body weight measurements of virally transduced mice. Neuron 1999 22, 167-178DOI: (10.1016/S0896-6273(00)80688-1)

Figure 3 Ambulatory Activity and Coordinated Locomotion of Wild-Type, DA−/−, and Virally Rescued Mice (A) Activity of wild-type (n = 8), DA−/− (n = 17), and virally rescued mice (THn = 3; Mixn = 20) was monitored over a 24 hr period in an activity chamber. *p < 0.05 compared to wild-type and DA−/− mice assessed 24 to 48 hr after their last L-DOPA injection. (B) Time spent on a rotarod by wild-type (n = 15), DA−/− (n = 15), and virally rescued mice (THn = 3; Mixn = 20). *p < 0.05 compared to wild-type mice. Neuron 1999 22, 167-178DOI: (10.1016/S0896-6273(00)80688-1)

Figure 4 Activity Measurements of DA−/− and Virally Rescued Mice Treated with L-DOPA DA−/− (n = 17) and rescued mice (Mixn = 15; THn = 3) were placed in an activity chamber and allowed to acclimate to the environment for 24 hr. Mice were then injected with L-DOPA (50 mg/kg body weight) or saline, and ambulations and food intake were monitored for 5 hr following administration of L-DOPA. Average activity of wild-type mice is indicated by dotted line; they do not respond to L-DOPA treatment. Neuron 1999 22, 167-178DOI: (10.1016/S0896-6273(00)80688-1)

Figure 5 Rotational Behavior of DA−/− Mice Injected Unilaterally with Mixed Vector Unilaterally injected mice (n = 4) were treated with L-DOPA (50 mg/kg body weight ) and returned to their homecage, and their activity over 15 min was videotaped at 1, 2, and 21 hr following treatment. The number of 360° clockwise or counterclockwise turns that occurred during these intervals was counted. Neuron 1999 22, 167-178DOI: (10.1016/S0896-6273(00)80688-1)

Figure 6 TH Immunohistochemistry in Various Brain Regions of Virally Transduced DA−/− Mice (A–C) Low-powered view of TH immunostaining in coronal sections of a rescued mouse transduced with rAAV-TH + rAAVGTPCH1 (Mouse #18Figure 7). Arrows denote TH-positive areas within dorsal structures, and arrowheads demarcate TH staining in ventral structures. (D) A high-powered view of boxed area in (A) shows TH immunostaining within ventral brain structures. TH-positive brain regions include the insular (Ins), dorsal endopiriform (DEn), and Piriform (Pir) corticies. Other areas of interest that are not stained include the lateral shell (LshNAc) and core (NAc) of the nucleus accumbens; bar represents 500 μm. (E and F) TH staining of cell bodies and fibers within the DEn (upper box from [D]), and Pir (lower box from [D]); bar = 100 μm. (G) A high-power view of TH-positive fibers found within the dorsal neocortex of a rescued mouse; bar = 100 μm. (H) TH immunostaining within the CPu of a mouse transduced with mixed virus (mouse #17 in Figure 7); bar = 500 μm. (I) GTPCH1 immunostaining in an adjacent section from mouse #17 demonstrates a similar pattern of GTPCH1 expression; bar = 500 μm. Neuron 1999 22, 167-178DOI: (10.1016/S0896-6273(00)80688-1)

Figure 7 Mapping of TH-Positive Areas in Virally Transduced Mice A color-coded key to various brain regions depicted in these sections is shown at top of left panel. Below are shown analyses of six mice treated with mixed virus. Right panel shows analysis of seven mice treated with rAAV-TH alone. Free-floating coronal sections spaced at 100 μm intervals and encompassing the entire brain were stained with TH antibody, and TH-positive areas were identified with a microscope under low magnification. Putative areas were then viewed under higher power to verify the presence of cell bodies. Regions containing cell bodies were scored as positive and are shown in green (dorsal structures) and red (ventral structures). Values for activity are reported in meters traveled over 24 hr (nd = not determined). Open boxes denote virally transduced mice that were not rescued for feeding, partially filled boxes represent partial rescue of feeding, and filled boxes full rescue. Diagrams of coronal sections were modified from Franklin and Paxinos 1997. Neuron 1999 22, 167-178DOI: (10.1016/S0896-6273(00)80688-1)

Figure 7 Mapping of TH-Positive Areas in Virally Transduced Mice A color-coded key to various brain regions depicted in these sections is shown at top of left panel. Below are shown analyses of six mice treated with mixed virus. Right panel shows analysis of seven mice treated with rAAV-TH alone. Free-floating coronal sections spaced at 100 μm intervals and encompassing the entire brain were stained with TH antibody, and TH-positive areas were identified with a microscope under low magnification. Putative areas were then viewed under higher power to verify the presence of cell bodies. Regions containing cell bodies were scored as positive and are shown in green (dorsal structures) and red (ventral structures). Values for activity are reported in meters traveled over 24 hr (nd = not determined). Open boxes denote virally transduced mice that were not rescued for feeding, partially filled boxes represent partial rescue of feeding, and filled boxes full rescue. Diagrams of coronal sections were modified from Franklin and Paxinos 1997. Neuron 1999 22, 167-178DOI: (10.1016/S0896-6273(00)80688-1)